Literature DB >> 9576634

CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls.

M Vrethem1, C Dahle, C Ekerfelt, P Forsberg, O Danielsson, J Ernerudh.   

Abstract

OBJECTIVES: To study the distribution of CD4+ and CD8+ T-cell subsets in cerebrospinal fluid (CSF) and peripheral blood from patients with multiple sclerosis (MS), meningitis, other neurological diseases and healthy controls.
MATERIAL AND METHODS: The expression of markers for naive and memory cells (CD45RA+ and CD45R0+), and helper/inducer cells (CD29+) on CD4+ cells as well as CD45R0+ and killer/effector (S6F1+) on CD8+ cells was investigated in cerebrospinal fluid (CSF) and peripheral blood from patients with multiple sclerosis (n=28), meningitis (n=13), other neurological diseases (n=16), and healthy controls (n=16) by 2-color flow cytometry.
RESULTS: The majority of T cells in the CSF of the 4 groups exhibited the phenotype of memory cells (CD45R0+) on both CD4+ and CD8+ cells. The proportion of helper/inducer (CD29+CD4+ in CD4+) cells was also larger in the CSF compared to peripheral blood in the 3 patient groups and controls investigated. In contrast, CD8+ cells with killer/effector (S6F1+) phenotype were fewer in CSF compared to peripheral blood in all 4 groups. There were no significant differences between patients and controls regarding the distribution of these activation markers in the CSF or peripheral blood.
CONCLUSION: Our observations support the notion that activated T cells of both CD4+ and CD8+ phenotype selectively pass the blood-brain barrier under both pathological and normal conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576634     DOI: 10.1111/j.1600-0404.1998.tb00640.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

Authors:  M J Robertson; R S Schacterle; G A Mackin; S N Wilson; K L Bloomingdale; J Ritz; A L Komaroff
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

2.  Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy.

Authors:  Sabrina Marangoni; Vincenza Argentiero; Bruno Tavolato
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

3.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.

Authors:  T L Sørensen; M Tani; J Jensen; V Pierce; C Lucchinetti; V A Folcik; S Qin; J Rottman; F Sellebjerg; R M Strieter; J L Frederiksen; R M Ransohoff
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

4.  Effect of photopheresis on lymphocyte population in children with newly diagnosed type 1 diabetes.

Authors:  J Ernerudh; J Ludvigsson; G Berlin; U Samuelsson
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

5.  Divergent Immunomodulation Capacity of Individual Myelin Peptides-Components of Liposomal Therapeutic against Multiple Sclerosis.

Authors:  Vilena V Ivanova; Svetlana F Khaiboullina; Marina O Gomzikova; Ekaterina V Martynova; André M Ferreira; Ekaterina E Garanina; Damir I Sakhapov; Yakov A Lomakin; Timur I Khaibullin; Evgenii V Granatov; Farit A Khabirov; Albert A Rizvanov; Alexander Gabibov; Alexey Belogurov
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

6.  The majority of infiltrating CD8 T lymphocytes in multiple sclerosis lesions is insensitive to enhanced PD-L1 levels on CNS cells.

Authors:  Camille L Pittet; Jia Newcombe; Jack P Antel; Nathalie Arbour
Journal:  Glia       Date:  2011-02-28       Impact factor: 7.452

7.  CSF-resident CD4+ T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis.

Authors:  James Hrastelj; Robert Andrews; Samantha Loveless; Joanne Morgan; Stefan Mark Bishop; Nicholas J Bray; Nigel M Williams; Neil P Robertson
Journal:  Brain Commun       Date:  2021-07-13

Review 8.  Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis.

Authors:  Océane Perdaens; Vincent van Pesch
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.